// App-Quantinova.ai

: The Relationship between Thrombin Generation Assay and FVIII Levels in Patients with Mild to Moderate Haemophilia (A)

Researchers

Presenter

  • Pu-Lin Luo

Principal Investigators

  • Steven K. Austin

  • Kiran Parmar

  • Dan P Hart

  • Michael Laffan

Medical Centers

  • Biomedical Research Centre, Guy's and St Thomas NHS Foundation Trust, London, United Kingdom

  • St George's Medical School, London, United Kingdom

  • St. George's Haemophilia Centre, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom

  • Guys and St Thomas Hospitals NHS Foundation Trust, London, UK

  • Royal London Haemophilia Centre, Barts and the London School of Medicine and Dentistry, London, United Kingdom

  • Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • Activated partial thromboplastin time

Drug/Treatment

  • Evithrom

  • FVIII

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A